Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.

Cancer immunology, immunotherapy : CII - 1 Mar 2022

Wu Pu, Sun Wei, Zhang Hao

Abstract excerpt

Thyroid carcinoma (THCA) is the most common endocrine malignancy, and its incidence is increasing worldwide. Several studies have explored whether the tumor immune microenvironment and immune-related genes (IRGs) influence the prognosis of patients with THCA and can be used to predict the response to immune checkpoint inhibitors (ICIs). We developed an IRG prognostic/risk signature using a bioinformatics method,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Checkpoint Inhibitors
Share to Immunity
Share to Lymphocytes, Tumor-Infiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Proportional Hazards Models

Share to ROC Curve

Share to Thyroid Neoplasms

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34398303
DOI: 10.1007/s00262-021-03020-4
PMCID: PMC10992838

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.PMID 34398303Read ↗

A Novel Signature to Predict Thyroid Cancer Prognosis and Immune Landscape Using Immune-Related LncRNA PairsSemantic proximity Read ↗

A novel immune-related eRNAs prognostic signature to predict the immunotherapy response for thyroid carcinomaSemantic proximity Read ↗

Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cellsSemantic proximity Read ↗

Identification of lncRNAs and immune-related prognostic genes as thyroid cancer microenvironment biomarkersSemantic proximity Read ↗

Identification of prognostic biomarkers related to the tumor microenvironment in thyroid carcinomaSemantic proximity Read ↗

Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid CancerSemantic proximity Read ↗

Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes.Semantic proximity Read ↗

Immune cell score model is a new tumor marker for predicting prognosis and selecting therapeutic drugs in thyroid cancerSemantic proximity Read ↗

Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinomaSemantic proximity Read ↗

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.Semantic proximity Read ↗

Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid CancerSemantic proximity Read ↗

A novel immune checkpoint-related signature for prognosis and immune analysis in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.